Special Advisory: Elite Diagnostic Limited (ELITE) 

December 24, 2021

Elite Diagnostic Limited (ELITE) has advised that following its previous advisory regarding the non-reappointment of Mr. Peter Chin as a Director of the Company effective December 14, 2021, a special meeting of the Company’s Board was held on December 23, 2021 to consider the relevant changes to the membership of its two subcommittees. Effective as at that date:

1. Kevin Donaldson has been appointed to the Audit Committee in place of Mr. Chin and the committee now comprises William Mahfood, Andre Ho Long and Kevin Donaldson. Mr. Ho Lung is the new Committee Chairman.

2. Mr. Chin has also been removed from the Corporate Governance & Compensation Committee and no new members were appointed. The Committee now comprises: William Mahfood (Chairman), Andre Ho Lung, Quentin Hugh Sam and mentor, Christopher Bovell.


Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein